NASDAQ: IKNAIkena Oncology Inc Stock Ownership - Who owns Ikena Oncology?
Insider buying vs selling
Have Ikena Oncology Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when IKNA insiders and whales buy or sell their stock.
IKNA Shareholders
What type of owners hold Ikena Oncology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Atlas Venture Life Science Advisors LLC | 10.40% | 5,018,178 | $6.52M | Institution |
| Blue Owl Capital Holdings LP | 8.48% | 4,091,118 | $5.32M | Institution |
| Bvf Inc | 8.30% | 4,006,564 | $5.21M | Institution |
| Bml Capital Management LLC | 7.43% | 3,585,866 | $4.66M | Institution |
| Orbimed Advisors LLC | 7.33% | 3,539,358 | $4.60M | Institution |
| Jean Francois Formela | 6.01% | 2,901,609 | $3.77M | Insider |
| Otello Stampacchia | 4.66% | 2,249,123 | $2.92M | Insider |
| Omega Fund Management LLC | 4.66% | 2,249,123 | $2.92M | Institution |
| Atlas Venture Fund XI LP | 4.39% | 2,116,569 | $2.75M | Insider |
| Gilead Sciences Inc | 4.16% | 2,008,338 | $2.61M | Institution |
IKNA vs Biotech Stocks
Ikena Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.